Metabolic

RC-S

Long-acting single-receptor metabolic research peptide studied for glycemic control and body-weight reduction.

For educational and research use only. Not intended for human or animal consumption. Always consult a qualified healthcare professional before starting any protocol.

Overview & mechanism

RC-S is a single-receptor incretin-class research peptide with structural modifications giving it a long half-life and resistance to enzymatic degradation. It enhances glucose-dependent insulin secretion, slows gastric emptying, and reduces appetite through central pathways. Published research in metabolic disease has shown substantial reductions in HbA1c and body weight.

Research dose & half-life

Half-life:: ~7 days
Research dose:: Standard research titration: 0.25 mg weekly x 4 wks → 0.5 → 1.0 → 1.7 → 2.4 mg weekly, subcutaneous.

Safety & side effects

Common: nausea, vomiting, diarrhea, constipation, reflux, fatigue, and injection-site reactions — usually worst after dose escalations. Serious: pancreatitis (severe persistent abdominal pain), gallbladder disease, dehydration/kidney injury from prolonged vomiting, and hypoglycemia if combined with insulin or sulfonylureas. Rodent studies in this class carry a medullary thyroid carcinoma / MEN2 warning — contraindicated with personal or family history. Avoid in pregnancy. Titrate slowly and maintain hydration and adequate protein intake.

Deep dive

How the titration schedule is designed

The step-up schedule (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly) exists to let the gut adapt to slowed emptying. Skipping steps is the single largest driver of severe nausea and dropout in published studies of this class. Most researchers hold at whichever step still produces meaningful appetite suppression rather than always escalating to the ceiling dose.

Protecting lean mass

Rapid weight loss on any incretin-class peptide shifts a portion of loss to lean tissue. Published protocols mitigate this with 1.2–1.6 g/kg/day of protein, resistance training 2–4x weekly, and avoiding aggressive caloric deficits during the highest-dose weeks. Bloodwork every 8–12 weeks (CMP, lipids, HbA1c) is standard when the research is long-running.

Reconstitution and storage

RC-S is typically reconstituted with bacteriostatic water to a workable concentration (commonly 2–4 mg/mL). Once reconstituted, refrigerate and use within roughly 28 days — the benzyl-alcohol preservative in bacteriostatic water extends usable life versus sterile water. See the reconstitution calculator for exact volume math.

Frequently asked questions

How long until RC-S starts suppressing appetite?

Most reports note appetite reduction within the first week at 0.25 mg, with the full effect at each dose appearing 3–4 weeks in as steady-state plasma levels are reached.

What day of the week should the dose be taken?

Any consistent day works. Many researchers choose Friday or Saturday so that peak nausea (usually 24–72 hours after injection) lands on a lower-activity day, especially in the first weeks after each dose increase.

Can RC-S be paused and restarted?

Yes. After a break longer than 2 weeks, most protocols restart at 0.25 mg rather than the previous top dose to let the gut re-adapt and minimize severe nausea.

How is RC-S stored?

Lyophilized vials are stable at room temperature short-term but are best kept refrigerated. Once reconstituted with bacteriostatic water, refrigerate and use within about 28 days.

Back to education library